Gastroenterology and Digestive Diseases

Hepatocellular Carcinoma

Submit Abstract Register Now

Hepatocellular carcinoma (HCC) also known as Liver cancer is a primary malignancy disorder of the liver occurring primarily in patients with chronic hepatitis and other liver diseases. Hepatocellular carcinoma is the 3^rd major leading cause of cancer-related deaths globally. The common symptoms are yellowish skin, severe abdominal swelling and pain, loss of appetite, weight loss, nausea, vomiting, and fatigue. People with chronic Hepatitis B and/ hepatitis C, patients with history of alcohol abuse, presence of aflatoxins, people with hemochromatosis, or with non-alcoholic steatohepatitis, type 2 diabetes, Wilson’s diseases, and Hemophilia, are at high risk of liver cancer. Treatment methods include surgical re-section, where surgeons remove the part of the liver having tumor while trying to preserve the healthy liver tissue. This method is not always desirable because only about 15% people globally are eligible for resection. Other most common treatment method is liver transplant. But, owing to the shortage of the organ with increasing list of patients for transplant, this option is not always recommended. The most common therapies prescribed by doctors are the Ablative therapies, viz., radiofrequency ablation (RFA), Cryo-ablation, Per-cutaneous ethanol injection, portal vein embolization, and potentially novel chemotherapeutic agents. These therapies help the patients in relieving the symptoms and provide relief.